Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lanza

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|April 14, 2006
Effects of mutations at conserved TM II residues on ligand binding and activation of mouse 5-HT6 receptorJiaping Zhang, Chun-Pyn Shen, Jing C Xiao, et al.
Journal of Vascular Surgery|November 1, 1995
Healing of venous ulcers in an ambulatory care program: the roles of chronic venous insufficiency and patient complianceC A Erickson, D J Lanza, D L Karp, et al.
Teratology|February 9, 2002
Effects of VLA-4 antagonists in rat whole embryo cultureStan Spence, Christine Vetter, William K Hagmann, et al.
Environmental Research|September 26, 2008
Mercury levels and fish consumption practices in women of child-bearing age in the Florida PanhandleNatalie K Karouna-Renier, K Ranga Rao, John J Lanza, et al.
Journal of Medicinal Chemistry|January 24, 1992
Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor bindingT J Lanza, P L Durette, T Rollins, et al.
Journal of Medicinal Chemistry|December 24, 1993
Inhibition of matrix metalloproteinases by N-carboxyalkyl peptidesK T Chapman, I E Kopka, P L Durette, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Bioisosteric replacement of anilide with benzoxazole: potent and orally bioavailable antagonists of VLA-4Linus S Lin, Thomas J Lanza, Laurie A Castonguay, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 9, 2010
In vitro and in vivo metabolism of a novel cannabinoid-1 receptor inverse agonist, taranabant, in rats and monkeysV B G Reddy, G A Doss, B V Karanam, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 17, 2008
Importance of mechanistic drug metabolism studies in support of drug discovery: A case study with an N -sulfonylated dipeptide VLA-4 antagonist in ratsW Tang, R A Stearns, Q Chen, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2010
Synthesis and cannabinoid-1 receptor binding affinity of conformationally constrained analogs of taranabantIhor E Kopka, Linus S Lin, James P Jewell, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|April 14, 2006
Effects of mutations at conserved TM II residues on ligand binding and activation of mouse 5-HT6 receptorJiaping Zhang, Chun-Pyn Shen, Jing C Xiao, et al.
Journal of Vascular Surgery|November 1, 1995
Healing of venous ulcers in an ambulatory care program: the roles of chronic venous insufficiency and patient complianceC A Erickson, D J Lanza, D L Karp, et al.
Teratology|February 9, 2002
Effects of VLA-4 antagonists in rat whole embryo cultureStan Spence, Christine Vetter, William K Hagmann, et al.
Environmental Research|September 26, 2008
Mercury levels and fish consumption practices in women of child-bearing age in the Florida PanhandleNatalie K Karouna-Renier, K Ranga Rao, John J Lanza, et al.
Journal of Medicinal Chemistry|January 24, 1992
Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor bindingT J Lanza, P L Durette, T Rollins, et al.
Journal of Medicinal Chemistry|December 24, 1993
Inhibition of matrix metalloproteinases by N-carboxyalkyl peptidesK T Chapman, I E Kopka, P L Durette, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Bioisosteric replacement of anilide with benzoxazole: potent and orally bioavailable antagonists of VLA-4Linus S Lin, Thomas J Lanza, Laurie A Castonguay, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 9, 2010
In vitro and in vivo metabolism of a novel cannabinoid-1 receptor inverse agonist, taranabant, in rats and monkeysV B G Reddy, G A Doss, B V Karanam, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 17, 2008
Importance of mechanistic drug metabolism studies in support of drug discovery: A case study with an N -sulfonylated dipeptide VLA-4 antagonist in ratsW Tang, R A Stearns, Q Chen, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2010
Synthesis and cannabinoid-1 receptor binding affinity of conformationally constrained analogs of taranabantIhor E Kopka, Linus S Lin, James P Jewell, et al.
Pageof 4